Abstract:The preoptic area is a well-established centre for the control of maternal behaviour. An intact medial preoptic area (MPOA) is required for maternal responsiveness as lesion of the area abolishes maternal behaviours. Whereas hormonal changes in the peripartum period contribute to the initiation of maternal responsiveness, inputs from pups are required for its maintenance. Neurones are activated in different parts of the MPOA in response to pup exposure. In the present review, we summarize the potential inputs … Show more
“…Rodent studies on the maternal brain -originating with Rosenblatt's studies (Rosenblatt and Lehrman, 1963;Rosenblatt, 2003;Rosenblatt et al, 1994), addressed the critical role of the medial pre-optic area (MPOA) in the hypothalamus for the initiation of maternal behavior. Primed by the hormones of pregnancy and triggered by the increase in oxytocin and prolactin during parturition, the MPOA projects to the mesolimbic dopamine circuits, including VTA and NAcc, which increases maternal motivation to care for infants and places incentive value on stimuli from the child (Dobolyi et al, 2014;Numan and Stolzenberg, 2009;Shahrokh et al, 2010). The MPOA also projects to the amygdala, which increases maternal vigilance for infant safety (Been and Petrulis, 2012;Sheehan et al, 2001).…”
“…Rodent studies on the maternal brain -originating with Rosenblatt's studies (Rosenblatt and Lehrman, 1963;Rosenblatt, 2003;Rosenblatt et al, 1994), addressed the critical role of the medial pre-optic area (MPOA) in the hypothalamus for the initiation of maternal behavior. Primed by the hormones of pregnancy and triggered by the increase in oxytocin and prolactin during parturition, the MPOA projects to the mesolimbic dopamine circuits, including VTA and NAcc, which increases maternal motivation to care for infants and places incentive value on stimuli from the child (Dobolyi et al, 2014;Numan and Stolzenberg, 2009;Shahrokh et al, 2010). The MPOA also projects to the amygdala, which increases maternal vigilance for infant safety (Been and Petrulis, 2012;Sheehan et al, 2001).…”
“…In addition, prolactin is also known as an important factor that mediates adaptive responses related to maternal behaviors. In this case, the effects of prolactin on maternal care depend on neurons distributed in the preoptic area (29). In rodents, maternal care can be analyzed by evaluating the latency of the animal to exhibit behaviors, such as retrieving pups to the nest, grouping them and crouching over them for a set amount of time.…”
Section: The Hypothalamus As a Target Of Prolactin To Modulate Severamentioning
Prolactin is best known for its effects of stimulating mammary gland development and lactogenesis. However, prolactin is a pleiotropic hormone that is able to affect several physiological functions, including fertility. Prolactin receptors (PRLRs) are widely expressed in several tissues, including several brain regions and reproductive tract organs. Upon activation, PRLRs may exert prolactin's functions through several signaling pathways, although the recruitment of the signal transducer and activator of transcription 5 causes most of the known effects of prolactin. Pathological hyperprolactinemia is mainly due to the presence of a prolactinoma or pharmacological effects induced by drugs that interact with the dopamine system. Notably, hyperprolactinemia is a frequent cause of reproductive dysfunction and may lead to infertility in males and females. Recently, several studies have indicated that prolactin may modulate the reproductive axis by acting on specific populations of hypothalamic neurons that express the Kiss1 gene. The Kiss1 gene encodes neuropeptides known as kisspeptins, which are powerful activators of gonadotropin-releasing hormone neurons. In the present review, we will summarize the current knowledge about prolactin's actions on reproduction. Among other aspects, we will discuss whether the interaction between prolactin and the Kiss1-expressing neurons can affect reproduction and how kisspeptins may become a novel therapeutic approach to treat prolactin-induced infertility. Arch Endocrinol Metab. 2016;60(6):587-95
“…The medial preoptic area (MPOA) is a well-established centre for the control of maternal behavior [25] . It expresses receptors of hormones that enhance parental behaviors and neurons in this area activate when a mouse or rat takes care of her pups [4] .…”
Section: Medial Preoptic Areamentioning
confidence: 99%
“…An intact MPOA is required for maternal responsiveness because lesions of this area disrupt maternal behaviors such as pup retrieval, nest building, nursing and maternal aggression [26] . Neurons in different parts of the MPOA are activated with pup exposure [25] and stimulation of this brain area is sufficient to activate maternal responses [26] . Different subregions or neuron populations within the MPOA may influence differently specific aspects of maternal behavior [4] .…”
Maternal behavior is probably the most important pro-social behavior in female mammals, ensuring both the development and survival of her offspring. Signals driving maternal behaviors are complex and involve several brain areas, most of which are innervated by serotonin. Serotonin transmission influences maternal processes indirectly through release of maternally-relevant hormones such as prolactin, oxytocin and vasopressin, but it can also have more direct effects on survival and the growth rate of offspring, as well as on maternal care, aggression and pup killing. This article aims to examine the basics of the components of maternal behaviors in rodents and the neural systems underpinning these maternal responses with special emphasis on the role of neural serotonin in the regulation of these behaviors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.